| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
NanomedicineStructure determination between tissue level and single molecule localization and molecular imagingMRT (Instrumentation)Atherosclerosis (BASKET)AidsAptamerDrug deliveryLaboratory medicineStructure determination at molecular level and finerSurface plasmon resonanceOptics and wavesSputteringEnzyme structure and chemistry Tpy chemistryOptical micromanipulationRNA (MicroRNA)NanocoloniesRegeneration of tissues and other biologic structuresGene transferAmyloidosisProtein (folding)Thrombosis (BASKET)Infection (Imaging)Contrast agents (X ray contrast agents)Research ethicsElectron tomography| 1 | 2007 | Nanoparticles-a thoracic toxicology perspective. | 
| + | - | nl | Yonsei Med J 48(4):561-72 (2007) |
| 2 | 2010 | Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. | 
| + | - | nl | J Cereb Blood Flow Metab 30(1):15-35 (2010) Weinstein JS |
| 3 | 2007 | Nanoparticles: pharmacological and toxicological significance. | 
| + | - | nl | Br J Pharmacol 150(5):552-8 (2007) |
| 4 | 2001 | Long-circulating and target-specific nanoparticles: theory to practice. | 
| + | - | nl | Pharmacol Rev 53(2):283-318 (2001) |
| 5 | 2000 | Nano and microparticles as controlled drug delivery devices. | 
| + | - | nl | J Pharm Pharm Sci 3(2):234-58 (2000) |
| 6 | 2006 | Nanocarriers: promising vehicle for bioactive drugs. | 
| + | - | nl | Biol Pharm Bull 29(9):1790-8 (2006) |
| 7 | 2008 | Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives. | 
| + | - | nl | Indian J Pharm Sci 70(4):431-9 (2008) |
| 8 | 2008 | Factors affecting the clearance and biodistribution of polymeric nanoparticles. | 
| + | - | nl | Mol Pharm 5(4):505-15 (2008) |
| 9 | 2008 | Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. | 
| + | - | nl | Mol Pharm 5(4):487-95 (2008) |
| 10 | 2010 | Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. | 
| + | - | nl | Part Fibre Toxicol 7(-):3 (2010) |
| 11 | 2010 | Deposition and biokinetics of inhaled nanoparticles. | 
| + | - | nl | Part Fibre Toxicol 7(-):2 (2010) |
| 12 | 2007 | Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases. | 
| + | - | nl | Part Fibre Toxicol 4(-):4 (2007) |
| 13 | 2006 | The potential risks of nanomaterials: a review carried out for ECETOC. | 
| + | - | nl | Part Fibre Toxicol 3(-):11 (2006) |
| 14 | 2005 | Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. | 
| + | - | nl | Part Fibre Toxicol 2(-):10 (2005) |
| 15 | 2009 | On the toxicity of therapeutically used nanoparticles: an overview. | 
| + | - | nl | J Toxicol 2009(-):754810 (2009) |
| 16 | 2010 | Biomimetic nanoparticles: preparation, characterization and biomedical applications. | 
| + | - | nl | Int J Nanomedicine 5(-):249-59 (2010) |
| 17 | 2010 | Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation. | 
| + | - | nl | Int J Nanomedicine 5(-):37-49 (2010) |
| 18 | 2009 | Nanomedicine in pulmonary delivery. | 
| + | - | nl | Int J Nanomedicine 4(-):299-319 (2009) |
| 19 | 2009 | Biomedical applications of functionalized fullerene-based nanomaterials. | 
| + | - | nl | Int J Nanomedicine 4(-):261-75 (2009) |
| 20 | 2009 | Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. | 
| + | - | nl | Int J Nanomedicine 4(-):1-7 (2009) |
| 21 | 2008 | Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. | 
| + | - | nl | Int J Nanomedicine 3(3):311-21 (2008) |
| 22 | 2008 | Nanocrystal technology, drug delivery and clinical applications. | 
| + | - | nl | Int J Nanomedicine 3(3):295-309 (2008) |
| 23 | 2008 | Radionuclide carriers for targeting of cancer. | 
| + | - | nl | Int J Nanomedicine 3(2):181-99 (2008) |
| 24 | 2008 | Magnetic nanoparticles for gene and drug delivery. | 
| + | - | nl | Int J Nanomedicine 3(2):169-80 (2008) |
| 25 | 2008 | Drug delivery and nanoparticles:applications and hazards. | 
| + | - | nl | Int J Nanomedicine 3(2):133-49 (2008) |
| 26 | 2008 | NanoTox: hysteria or scientific studies? | 
| + | - | nl | Int J Nanomedicine 3(2):i-ii (2008) |
| 27 | 2008 | Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. | 
| + | - | nl | Int J Nanomedicine 3(1):1-19 (2008) |
| 28 | 2008 | Novel opportunities and challenges offered by nanobiomaterials in tissue engineering. | 
| + | - | nl | Int J Nanomedicine 3(4):415-24 (2008) |
| 29 | 2007 | Medicinal applications of fullerenes. | 
| + | - | nl | Int J Nanomedicine 2(4):639-49 (2007) |
| 30 | 2007 | Biomimetic and bioactive nanofibrous scaffolds from electrospun composite nanofibers. | 
| + | - | nl | Int J Nanomedicine 2(4):623-38 (2007) |
| 31 | 2007 | Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. | 
| + | - | nl | Int J Nanomedicine 2(4):609-22 (2007) |
| 32 | 2007 | Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles. | 
| + | - | nl | Int J Nanomedicine 2(4):595-607 (2007) |
| 33 | 2007 | VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection. | 
| + | - | nl | Int J Nanomedicine 2(4):561-6 (2007) |
| 34 | 2007 | Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles. | 
| + | - | nl | Int J Nanomedicine 2(4):541-50 (2007) |
| 35 | 2007 | Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. | 
| + | - | nl | Int J Nanomedicine 2(4):515-26 (2007) |
| 36 | 2007 | Cellular response to low adhesion nanotopographies. | 
| + | - | nl | Int J Nanomedicine 2(3):373-81 (2007) |
| 37 | 2007 | Biocompatibility and applications of carbon nanotubes in medical nanorobots. | 
| + | - | nl | Int J Nanomedicine 2(3):361-72 (2007) |
| 38 | 2007 | Nanoparticulate systems for polynucleotide delivery. | 
| + | - | nl | Int J Nanomedicine 2(3):353-60 (2007) |
| 39 | 2007 | Imaging and manipulating the structural machinery of living cells on the micro- and nanoscale. | 
| + | - | nl | Int J Nanomedicine 2(3):333-44 (2007) |
| 40 | 2007 | Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. | 
| + | - | nl | Int J Nanomedicine 2(3):289-300 (2007) |
| 41 | 2007 | Nanoparticulate carriers for the treatment of coronary restenosis. | 
| + | - | nl | Int J Nanomedicine 2(2):143-61 (2007) |
| 42 | 2007 | Nanoparticles in modern medicine: state of the art and future challenges. | 
| + | - | nl | Int J Nanomedicine 2(2):129-41 (2007) |
| 43 | 2006 | Chitosan nanoparticles for oral drug and gene delivery. | 
| + | - | nl | Int J Nanomedicine 1(2):117-28 (2006) |
| 44 | 2006 | Nanomedicine: what's in a definition? | 
| + | - | nl | Int J Nanomedicine 1(2):115-6 (2006) |
| 45 | 2006 | Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices. | 
| + | - | nl | Int J Nanomedicine 1(4):483-95 (2006) |
| 46 | 2006 | Silicon nanoparticles: applications in cell biology and medicine. | 
| + | - | nl | Int J Nanomedicine 1(4):451-72 (2006) |
| 47 | 2006 | Nanofibers and their applications in tissue engineering. | 
| + | - | nl | Int J Nanomedicine 1(1):15-30 (2006) |
| 48 | 2006 | Micro- and nanotechnology in cell separation. | 
| + | - | nl | Int J Nanomedicine 1(1):3-14 (2006) |
| 49 | 2006 | Gadonanotubes as new high-performance MRI contrast agents. | 
| + | - | nl | Int J Nanomedicine 1(3):291-5 (2006) |
| 50 | 2010 | Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. | 
| + | - | nl | Nanoscale 2(9):1596-610 (2010) |
| 51 | 2010 | One-dimensional boron nanostructures: Prediction, synthesis, characterizations, and applications. | 
| + | - | nl | Nanoscale 2(8):1375-89 (2010) |
| 52 | 2010 | Properties, synthesis, and growth mechanisms of carbon nanotubes with special focus on thermal chemical vapor deposition. | 
| + | - | nl | Nanoscale 2(8):1306-23 (2010) |
| 53 | 2010 | The geometric structure of single-walled nanotubes. | 
| + | - | nl | Nanoscale 2(6):859-72 (2010) |
| 54 | 2010 | Carbon nanotubes: promising agents against free radicals. | 
| + | - | nl | Nanoscale 2(3):373-80 (2010) |
| 55 | 2010 | Nanoneedle: a multifunctional tool for biological studies in living cells. | 
| + | - | nl | Nanoscale 2(3):363-72 (2010) |
| 56 | 2010 | Quantum sized, thiolate-protected gold nanoclusters. | 
| + | - | nl | Nanoscale 2(3):343-62 (2010) |
| 57 | 2010 | Small organic molecule templating synthesis of organic-inorganic hybrid materials: their nanostructures and properties. | 
| + | - | nl | Nanoscale 2(3):323-34 (2010) |
| 58 | 2010 | DNA-based nanostructures for molecular sensing. | 
| + | - | nl | Nanoscale 2(2):188-97 (2010) |
| 59 | 2010 | One-dimensional CdS nanostructures: synthesis, properties, and applications. | 
| + | - | nl | Nanoscale 2(2):168-87 (2010) |
| 60 | 2009 | Mechanised nanoparticles for drug delivery. | 
| + | - | nl | Nanoscale 1(1):16-39 (2009) |
| 61 | 2007 | Review: nanoparticles in delivery of cardiovascular drugs. | 
| + | - | nl | Pak J Pharm Sci 20(4):340-8 (2007) |
| 62 | 2007 | Fabrication of solid nanoparticles for drug delivery. | 
| + | - | nl | Pak J Pharm Sci 20(3):251-9 (2007) |
| 63 | 2006 | Review: nanoparticles in drug delivery for the treatment of cancer. | 
| + | - | nl | Pak J Pharm Sci 19(3):258-68 (2006) |
| 64 | 2006 | Porous nanoparticles in drug delivery systems. | 
| + | - | nl | Pak J Pharm Sci 19(2):158-69 (2006) |
| 65 | 2006 | Fabrication of nanoparticles within polymeric pores for controlled release of drug. | 
| + | - | nl | Pak J Pharm Sci 19(1):73-84 (2006) |
| 66 | 2007 | Nanotechnology in biodevices. | 
| + | - | nl | J Microbiol Biotechnol 17(1):5-14 (2007) |
| 67 | 2005 | Nanotechnology for the biologist. | 
| + | - | nl | J Leukoc Biol 78(3):585-94 (2005) |
| 68 | 2009 | Single walled carbon nanotubes as reporters for the optical detection of glucose. | 
| + | - | nl | J Diabetes Sci Technol 3(2):242-52 (2009) |
| 69 | 2007 | Colloidal lithography and current fabrication techniques producing in-plane nanotopography for biological applications. | 
| + | - | nl | J R Soc Interface 4(12):1-17 (2007) |
| 70 | 2009 | Manipulation of biological samples using micro and nano techniques. | 
| + | - | nl | Integr Biol (Camb) 1(1):30-42 (2009) |
| 71 | 2009 | Microfluidic sample preparation: cell lysis and nucleic acid purification. | 
| + | - | nl | Integr Biol (Camb) 1(10):574-86 (2009) |
| 72 | 2009 | Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications. | 
| + | - | nl | Integr Biol (Camb) 1(7):446-51 (2009) |
| 73 | 2009 | Nanovaccines: recent developments in vaccination. | 
| + | - | nl | J Biosci 34(6):995-1003 (2009) |
| 74 | 2007 | Analytical nanobiotechnology for medicine diagnostics. | 
| + | - | nl | Mol Biosyst 3(5):336-42 (2007) |
| 75 | 2010 | Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions. | 
| + | - | nl | Angiogenesis 13(2):189-202 (2010) Lanza GM |
| 76 | 2009 | Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis. | 
| + | - | nl | Angiogenesis 12(4):325-38 (2009) |
| 77 | 2008 | Toxicogenomics to improve comprehension of the mechanisms underlying responses of in vitro and in vivo systems to nanomaterials: a review. | 
| + | - | nl | Curr Genomics 9(8):571-85 (2008) |
| 78 | 2006 | Nanoparticles and their biological and environmental applications. | 
| + | - | nl | J Biosci Bioeng 102(1):1-7 (2006) |
| 79 | 2005 | Medical application of functionalized magnetic nanoparticles. | 
| + | - | nl | J Biosci Bioeng 100(1):1-11 (2005) |
| 80 | 2007 | Biogenesis of microbial polyhydroxyalkanoate granules: a platform technology for the production of tailor-made bioparticles. | 
| + | - | nl | Curr Issues Mol Biol 9(1):41-62 (2007) |
| 81 | 2007 | Using micro-electro-mechanical systems (MEMS) to develop diagnostic tools. | 
| + | - | nl | J Vis Exp -(8):314 (2007) |
| 82 | 2007 | Nanotechnology-based drug delivery systems. | 
| + | - | nl | J Occup Med Toxicol 2(-):16 (2007) |
| 83 | 2008 | Polymeric micellar delivery systems in oncology. | 
| + | - | nl | Jpn J Clin Oncol 38(12):793-802 (2008) |
| 84 | 2008 | Nanoparticles for imaging and tumor gene delivery. | 
| + | - | nl | Tumori 94(2):264-70 (2008) |
| 85 | 2008 | Delivery of small interfering RNA. A review and an example of application to a junction oncogene. | 
| + | - | nl | Tumori 94(2):254-63 (2008) |
| 86 | 2008 | Towards safe nanoparticle technologies for nucleic acid therapeutics. | 
| + | - | nl | Tumori 94(2):234-45 (2008) |
| 87 | 2008 | MR and iron magnetic nanoparticles. Imaging opportunities in preclinical and translational research. | 
| + | - | nl | Tumori 94(2):226-33 (2008) |
| 88 | 2008 | Nanotechnology applications in medicine. | 
| + | - | nl | Tumori 94(2):206-15 (2008) |
| 89 | 2009 | Imaging applications of nanotechnology in cancer. | 
| + | - | nl | Target Oncol 4(3):169-81 (2009) Gunasekera UA |
| 90 | 2006 | Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. | 
| + | - | nl | Mol Cancer Ther 5(8):1909-17 (2006) |
| 91 | 2008 | Therapeutic nanoparticles for drug delivery in cancer. | 
| + | - | nl | Clin Cancer Res 14(5):1310-6 (2008) |
| 92 | 2008 | Pulmonary applications and toxicity of engineered nanoparticles. | 
| + | - | nl | Am J Physiol Lung Cell Mol Physiol 295(3):L400-11 (2008) |
| 93 | 2008 | Interactions of nanoparticles with pulmonary structures and cellular responses. | 
| + | - | nl | Am J Physiol Lung Cell Mol Physiol 294(5):L817-29 (2008) |
| 94 | 2005 | Smaller is not always better: nanotechnology yields nanotoxicology. | 
| + | - | nl | Am J Physiol Lung Cell Mol Physiol 289(5):L696-7 (2005) Kipen HM |
| 95 | 2008 | From systemic shotgun to site-specific nanoparticle-targeted delivery: a new paradigm for drug delivery. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 28(11):1879-81 (2008) Sarembock IJ |
| 96 | 2009 | Application of semiconductor and metal nanostructures in biology and medicine. | 
| + | - | nl | Hematology Am Soc Hematol Educ Program -(-):701-7 (2009) |
| 97 | 2005 | Drug transport to brain with targeted nanoparticles. | 
| + | - | nl | NeuroRx 2(1):108-19 (2005) |
| 98 | 2007 | Probing the interactions of proteins and nanoparticles. | 
| + | - | nl | Proc Natl Acad Sci U S A 104(7):2029-30 (2007) Klein J |
| 99 | 2006 | Microscale technologies for tissue engineering and biology. | 
| + | - | nl | Proc Natl Acad Sci U S A 103(8):2480-7 (2006) |
| 100 | 2008 | Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. | 
| + | - | nl | Swiss Med Wkly 138(27-28):387-91 (2008) |
| 101 | 2008 | Nanotechnology safety concerns revisited. | 
| + | - | nl | Toxicol Sci 101(1):4-21 (2008) |
| 102 | 2007 | Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. | 
| + | - | nl | Toxicol Sci 95(2):300-12 (2007) |
| 103 | 2006 | Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. | 
| + | - | nl | Toxicol Sci 92(1):5-22 (2006) |
| 104 | 2006 | Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials. | 
| + | - | nl | Toxicol Sci 91(1):14-9 (2006) |
| 105 | 2006 | Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. | 
| + | - | nl | Toxicol Sci 90(2):296-303 (2006) |
| 106 | 2006 | Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. | 
| + | - | nl | Toxicol Sci 90(1):23-32 (2006) |
| 107 | 2006 | Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. | 
| + | - | nl | Toxicol Sci 89(1):42-50 (2006) |
| 108 | 2005 | Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs. | 
| + | - | nl | Toxicol Sci 88(1):12-7 (2005) |
| 109 | 2005 | Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials. | 
| + | - | nl | Toxicol Sci 87(2):316-21 (2005) |
| 110 | 2004 | Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. | 
| + | - | nl | Toxicol Sci 77(1):3-5 (2004) |
| 111 | 2008 | New opportunities: the use of nanotechnologies to manipulate and track stem cells. | 
| + | - | nl | Cell Stem Cell 3(2):136-46 (2008) |
| 112 | 2009 | State of academic knowledge on toxicity and biological fate of quantum dots. | 
| + | - | nl | Toxicol Sci 112(2):276-96 (2009) |
| 113 | 2010 | Nanotechnology in ophthalmology. | 
| + | - | nl | Can J Ophthalmol 45(5):457-76 (2010) |
| 114 | 2010 | Paramagnetic liposome nanoparticles for cellular and tumour imaging. | 
| + | - | nl | Int J Mol Sci 11(4):1759-76 (2010) |
| 115 | 2009 | The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system. | 
| + | - | nl | Int J Mol Sci 10(9):3776-92 (2009) |
| 116 | 2009 | Novel applications of nanotechnology in medicine. | 
| + | - | nl | Indian J Med Res 130(6):689-701 (2009) |
| 117 | 2009 | Uses of nanoparticles for central nervous system imaging and therapy. | 
| + | - | nl | AJNR Am J Neuroradiol 30(7):1293-301 (2009) |
| 118 | 2002 | The potential value of iron oxide nanoparticles in brain tumor treatment. | 
| + | - | nl | AJNR Am J Neuroradiol 23(4):505 (2002) |
| 119 | 2010 | Wide contact structures for low-noise nanochannel devices based on a carbon nanotube network. | 
| + | - | nl | ACS Nano 4(12):7612-8 (2010) |
| 120 | 2011 | A boost for the emerging field of RNA nanotechnology. | 
| + | - | nl | ACS Nano 5(5):3405-18 (2011) |
| 121 | 2008 | Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. | 
| + | - | nl | ACS Nano 2(5):889-96 (2008) |
| 122 | 2010 | AIDS treatment with novel anti-HIV compounds improved by nanotechnology. | 
| + | - | nl | AAPS J 12(3):272-8 (2010) |
| 123 | 2007 | Nanosystems for simultaneous imaging and drug delivery to T cells. | 
| + | - | nl | AAPS J 9(2):E171-80 (2007) |
| 124 | 2011 | Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. | 
| + | - | nl | Acc Chem Res 44(10):842-52 (2011) |
| 125 | 2011 | Lipoprotein-inspired nanoparticles for cancer theranostics. | 
| + | - | nl | Acc Chem Res 44(10):1105-13 (2011) |
| 126 | 2007 | Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? | 
| + | - | nl | Acc Chem Res 40(5):335-42 (2007) |
| 127 | 2010 | Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. | 
| + | - | nl | Adv Drug Deliv Rev 62(6):592-605 (2010) |
| 128 | 2007 | Biodegradable nanoparticles for cytosolic delivery of therapeutics. | 
| + | - | nl | Adv Drug Deliv Rev 59(8):718-28 (2007) |
| 129 | 2007 | Functional electrospun nanofibrous scaffolds for biomedical applications. | 
| + | - | nl | Adv Drug Deliv Rev 59(14):1392-412 (2007) |
| 130 | 2009 | In vitro assessments of nanomaterial toxicity. | 
| + | - | nl | Adv Drug Deliv Rev 61(6):438-56 (2009) |
| 131 | 2009 | Effects of nanomaterial physicochemical properties on in vivo toxicity. | 
| + | - | nl | Adv Drug Deliv Rev 61(6):457-66 (2009) |
| 132 | 2009 | Magnetic nanoparticles for theragnostics. | 
| + | - | nl | Adv Drug Deliv Rev 61(6):467-77 (2009) |
| 133 | 2008 | Magnetic nanoparticles in MR imaging and drug delivery. | 
| + | - | nl | Adv Drug Deliv Rev 60(11):1252-65 (2008) |
| 134 | 2008 | Multifunctional magnetic nanoparticles for targeted imaging and therapy. | 
| + | - | nl | Adv Drug Deliv Rev 60(11):1241-51 (2008) |
| 135 | 2010 | Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. | 
| + | - | nl | Adv Drug Deliv Rev 62(3):346-61 (2010) |
| 136 | 2010 | Nanoparticles for detection and diagnosis. | 
| + | - | nl | Adv Drug Deliv Rev 62(3):316-28 (2010) |
| 137 | 2010 | Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. | 
| + | - | nl | Adv Drug Deliv Rev 62(3):284-304 (2010) |
| 138 | 2010 | Targeted hyperthermia using metal nanoparticles. | 
| + | - | nl | Adv Drug Deliv Rev 62(3):339-45 (2010) |
| 139 | 2010 | Modified natural nanoparticles as contrast agents for medical imaging. | 
| + | - | nl | Adv Drug Deliv Rev 62(3):329-38 (2010) |
| 140 | 2010 | Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. | 
| + | - | nl | Adv Drug Deliv Rev 62(4-5):518-31 (2010) |
| 141 | 2010 | Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. | 
| + | - | nl | Adv Drug Deliv Rev 62(4-5):408-23 (2010) |
| 142 | 2011 | Nanotechnology for energy-based cancer therapies. | 
| + | - | nl | Am J Cancer Res 1(4):508-20 (2011) |
| 143 | 2010 | Carbon nanotubes in neuroscience. | 
| + | - | nl | Acta Neurochir Suppl 106(-):337-41 (2010) |
| 144 | 2009 | Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. | 
| + | - | nl | Photochem Photobiol 85(1):21-32 (2009) |
| 145 | 2010 | Knitting complex weaves with DNA origami. | 
| + | - | nl | Curr Opin Struct Biol 20(3):276-82 (2010) |
| 146 | 2010 | Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. | 
| + | - | nl | Biopolymers 94(1):1-18 (2010) |
| 147 | 2010 | Emerging synergy between nanotechnology and implantable biosensors: a review. | 
| + | - | nl | Biosens Bioelectron 25(7):1553-65 (2010) |
| 148 | 2010 | DNA-based applications in nanobiotechnology. | 
| + | - | nl | J Biomed Biotechnol 2010(-):715295 (2010) |
| 149 | 2010 | Rationale for a nanomedicine approach to thrombolytic therapy. | 
| + | - | nl | Stroke 41(10 Suppl):S42-4 (2010) |
| 150 | 2010 | Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 368(1924):3683-712 (2010) |
| 151 | 2010 | Determining the size-dependent structure of ligand-free gold-cluster ions. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 368(1915):1211-43 (2010) |
| 152 | 2010 | Syntheses, structures and properties of primarily nanosized homo/heterometallic palladium CO/PR3-ligated clusters. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 368(1915):1301-32 (2010) |
| 153 | 2010 | Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 368(1915):1333-83 (2010) |
| 154 | 2010 | On the application potential of gold nanoparticles in nanoelectronics and biomedicine. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 368(1915):1405-53 (2010) |
| 155 | 2004 | Decoration of surfaces with size-selected clusters and molecular manipulation at room temperature: precision and uncertainty in organizing atoms. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1819):1195-205 (2004) |
| 156 | 2004 | Atomic-scale STM experiments on semiconductor surfaces: towards molecular nanomachines. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1819):1217-26 (2004) |
| 157 | 2004 | Near-field photonic forces. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1817):719-37 (2004) |
| 158 | 2004 | Sputtering: survey of observations and derived principles. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1814):29-53 (2004) |
| 159 | 2004 | Raman spectroscopy of fullerenes and fullerene-nanotube composites. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1824):2375-406 (2004) |
| 160 | 2004 | Raman spectroscopy of amorphous, nanostructured, diamond-like carbon, and nanodiamond. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1824):2477-512 (2004) |
| 161 | 2004 | Shape and complexity at the atomic scale: the case of layered nanomaterials. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2039-63 (2004) |
| 162 | 2004 | Electronic, thermal and mechanical properties of carbon nanotubes. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2065-98 (2004) |
| 163 | 2004 | Inorganic nanotubes. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2099-125 (2004) |
| 164 | 2004 | Novel nanoscale architectures: coated nanotubes and other nanowires. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2127-42 (2004) |
| 165 | 2004 | Controlled growth of carbon nanotubes. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2143-60 (2004) |
| 166 | 2004 | Syntheses and properties of B-C-N and BN nanostructures. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2161-86 (2004) |
| 167 | 2004 | Scanning tunnelling microscopy of carbon nanotubes. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2187-203 (2004) |
| 168 | 2004 | Formation and transformation of carbon nanoparticles under electron irradiation. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2205-22 (2004) |
| 169 | 2004 | Applications of carbon nanotubes in the twenty-first century. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2223-38 (2004) |
| 170 | 2004 | Carbon nanotube electron sources and applications. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 362(1823):2239-66 (2004) |
| 171 | 2003 | The carbon nanocosmos: novel materials for the twenty-first century. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 361(1813):2789-806 (2003) |
| 172 | 2003 | Molecular bioelectronics. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 361(1813):2807-25 (2003) |
| 173 | 2008 | Effects of symmetry crossover in quantum transport in graphene and nanotubes. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 366(1863):221-9 (2008) |
| 174 | 2008 | Principles of atomic friction: from sticking atoms to superlubric sliding. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 366(1869):1383-404 (2008) |
| 175 | 2008 | Nanotribology and nanomechanics in nano/biotechnology. | 
| + | - | nl | Philos Transact A Math Phys Eng Sci 366(1870):1499-537 (2008) |
| 176 | 2009 | Dendrimer-based nanoparticles for cancer therapy. | 
| + | - | nl | Hematology Am Soc Hematol Educ Program -(-):708-19 (2009) |
| 177 | 2006 | Synthesis, properties and perspectives of hybrid nanocrystal structures. | 
| + | - | nl | Chem Soc Rev 35(11):1195-208 (2006) |
| 178 | 2006 | Synthesis, structure and properties of metal nanoclusters. | 
| + | - | nl | Chem Soc Rev 35(11):1162-94 (2006) |
| 179 | 2006 | Scanning near-field photolithography--surface photochemistry with nanoscale spatial resolution. | 
| + | - | nl | Chem Soc Rev 35(11):1150-61 (2006) |
| 180 | 2006 | Artificial nanomachines based on interlocked molecular species: recent advances. | 
| + | - | nl | Chem Soc Rev 35(11):1135-49 (2006) |
| 181 | 2006 | First blueprint, now bricks: DNA as construction material on the nanoscale. | 
| + | - | nl | Chem Soc Rev 35(11):1111-21 (2006) |
| 182 | 2006 | Molecular printboards: versatile platforms for the creation and positioning of supramolecular assemblies and materials. | 
| + | - | nl | Chem Soc Rev 35(11):1122-34 (2006) |
| 183 | 2006 | Molecular designer self-assembling peptides. | 
| + | - | nl | Chem Soc Rev 35(11):1105-10 (2006) |
| 184 | 2006 | Imparting size, shape, and composition control of materials for nanomedicine. | 
| + | - | nl | Chem Soc Rev 35(11):1095-104 (2006) |
| 185 | 2006 | Gold nanostructures: engineering their plasmonic properties for biomedical applications. | 
| + | - | nl | Chem Soc Rev 35(11):1084-94 (2006) |
| 186 | 2006 | Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. | 
| + | - | nl | Chem Soc Rev 35(11):1068-83 (2006) |
| 187 | 2006 | Recent progress on nanovehicles. | 
| + | - | nl | Chem Soc Rev 35(11):1043-55 (2006) |
| 188 | 2006 | Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. | 
| + | - | nl | Chem Soc Rev 35(11):1028-42 (2006) |
| 189 | 2010 | Rheological properties of peptide-based hydrogels for biomedical and other applications. | 
| + | - | nl | Chem Soc Rev 39(9):3528-40 (2010) |
| 190 | 2004 | Dendrimers in drug research. | 
| + | - | nl | Chem Soc Rev 33(1):43-63 (2004) |
| 191 | 2005 | Photoactive metallocyclodextrins: sophisticated supramolecular arrays for the construction of light activated miniature devices. | 
| + | - | nl | Chem Soc Rev 34(2):120-32 (2005) |
| 192 | 2007 | Self-assembled peptide nanostructures: the design of molecular building blocks and their technological utilization. | 
| + | - | nl | Chem Soc Rev 36(8):1263-9 (2007) |
| 193 | 2007 | Liquid crystalline dendrimers. | 
| + | - | nl | Chem Soc Rev 36(9):1495-513 (2007) |
| 194 | 2007 | Biologically active, synthetic ion transporters. | 
| + | - | nl | Chem Soc Rev 36(2):378-89 (2007) |
| 195 | 2007 | Supramolecular [60]fullerene chemistry on surfaces. | 
| + | - | nl | Chem Soc Rev 36(2):390-414 (2007) |
| 196 | 2007 | Photo-driven molecular devices. | 
| + | - | nl | Chem Soc Rev 36(1):77-92 (2007) |
| 197 | 2007 | Polyoxometalate clusters, nanostructures and materials: from self assembly to designer materials and devices. | 
| + | - | nl | Chem Soc Rev 36(1):105-21 (2007) |
| 198 | 2007 | Rotaxanes as ligands: from molecules to materials. | 
| + | - | nl | Chem Soc Rev 36(2):226-35 (2007) |
| 199 | 2007 | 2,2':6',2''-terpyridines: from chemical obscurity to common supramolecular motifs. | 
| + | - | nl | Chem Soc Rev 36(2):246-53 (2007) |
| 200 | 2007 | Calixarene-based multivalent ligands. | 
| + | - | nl | Chem Soc Rev 36(2):254-66 (2007) |
| 201 | 2007 | Functionalized cucurbiturils and their applications. | 
| + | - | nl | Chem Soc Rev 36(2):267-79 (2007) |
| 202 | 2007 | Supramolecular DNA recognition. | 
| + | - | nl | Chem Soc Rev 36(2):280-95 (2007) |
| 203 | 2007 | Supramolecular architectures generated by self-assembly of guanosine derivatives. | 
| + | - | nl | Chem Soc Rev 36(2):296-313 (2007) |
| 204 | 2007 | Release mechanisms for polyelectrolyte capsules. | 
| + | - | nl | Chem Soc Rev 36(4):636-49 (2007) |
| 205 | 2007 | Old materials with new tricks: multifunctional open-framework materials. | 
| + | - | nl | Chem Soc Rev 36(5):770-818 (2007) |
| 206 | 2005 | Stimuli responsive polymers for biomedical applications. | 
| + | - | nl | Chem Soc Rev 34(3):276-85 (2005) |
| 207 | 2009 | Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. | 
| + | - | nl | Chem Soc Rev 38(9):2532-42 (2009) |
| 208 | 2005 | Supramolecular gels: functions and uses. | 
| + | - | nl | Chem Soc Rev 34(10):821-36 (2005) |
| 209 | 2005 | Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. | 
| + | - | nl | Chem Soc Rev 34(11):970-94 (2005) |
| 210 | 2008 | Assembly of functional molecular nanostructures on surfaces. | 
| + | - | nl | Chem Soc Rev 37(3):490-504 (2008) |
| 211 | 2006 | Noncovalent interactions of molecules with single walled carbon nanotubes. | 
| + | - | nl | Chem Soc Rev 35(7):637-59 (2006) |
| 212 | 2006 | Size matters: why nanomaterials are different. | 
| + | - | nl | Chem Soc Rev 35(7):583-92 (2006) |
| 213 | 2008 | Optical micromanipulation. | 
| + | - | nl | Chem Soc Rev 37(1):42-55 (2008) |
| 214 | 2008 | Designing peptide based nanomaterials. | 
| + | - | nl | Chem Soc Rev 37(4):664-75 (2008) |
| 215 | 2009 | Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. | 
| + | - | nl | Br J Pharmacol 157(2):179-94 (2009) Fattal E |
| 216 | 2005 | Nanomedicine: current status and future prospects. | 
| + | - | nl | FASEB J 19(3):311-30 (2005) |
| 217 | 2009 | Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency. | 
| + | - | nl | Biochemistry (Mosc) 74(13):1567-74 (2009) |
| 218 | 2008 | Nanocolonies: detection, cloning, and analysis of individual molecules. | 
| + | - | nl | Biochemistry (Mosc) 73(13):1361-87 (2008) |
| 219 | 2010 | Metal-organic frameworks as potential drug carriers. | 
| + | - | nl | Curr Opin Chem Biol 14(2):262-8 (2010) |
| 220 | 2008 | Nano-biophotonics: new tools for chemical nano-analytics. | 
| + | - | nl | Curr Opin Chem Biol 12(5):497-504 (2008) |
| 221 | 2008 | Nanowire sensors for multiplexed detection of biomolecules. | 
| + | - | nl | Curr Opin Chem Biol 12(5):522-8 (2008) |
| 222 | 2010 | Self-organization of grafted polyelectrolyte layers via the coupling of chemical equilibrium and physical interactions. | 
| + | - | nl | Proc Natl Acad Sci U S A 107(12):5300-5 (2010) |
| 223 | 2008 | Tumour-targeted nanomedicines: principles and practice. | 
| + | - | nl | Br J Cancer 99(3):392-7 (2008) |
| 224 | 2007 | Exploiting nanotechnology to target cancer. | 
| + | - | nl | Br J Cancer 96(9):1315-9 (2007) |
| 225 | 2002 | Nanotechnology and applications: an all-language literature survey including books and patents. | 
| + | - | nl | Clin Chem 48(4):662-5 (2002) |
| 226 | 2007 | Applications of nanobiotechnology in clinical diagnostics. | 
| + | - | nl | Clin Chem 53(11):2002-9 (2007) |
| 227 | 2006 | Nanodiagnostics: a new frontier for clinical laboratory medicine. | 
| + | - | nl | Clin Chem 52(7):1238-46 (2006) |
| 228 | 2010 | Superparamagnetic nanoparticles - a tool for early diagnostics. | 
| + | - | nl | Swiss Med Wkly 140(-):w13081 (2010) |
| 229 | 2007 | Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. | 
| + | - | nl | Environ Health Perspect 115(11):1654-9 (2007) |
| 230 | 2007 | In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what? | 
| + | - | nl | Environ Health Perspect 115(2):187-94 (2007) |
| 231 | 2010 | Nanodermatology: a bright glimpse just beyond the horizon - part I. | 
| + | - | nl | Skin Therapy Lett 15(8):1-4 (2010) |
| 232 | 2011 | Biomimetic nanostructured materials: potential regulators for osteogenesis? | 
| + | - | nl | Ann Acad Med Singapore 40(5):213-10 (2011) |
| 233 | 2010 | Synthesis, characterization, and application of 1-d cerium oxide nanomaterials: a review. | 
| + | - | nl | Int J Mol Sci 11(9):3226-51 (2010) |
| 234 | 2011 | Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications. | 
| + | - | nl | Int J Mol Sci 12(6):3888-927 (2011) |
| 235 | 2011 | Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel. | 
| + | - | nl | Int J Mol Sci 12(7):4395-413 (2011) |
| 236 | 2011 | Nanoparticles and neurotoxicity. | 
| + | - | nl | Int J Mol Sci 12(9):6267-80 (2011) |
| 237 | 2011 | Functioning nanomachines seen in real-time in living bacteria using single-molecule and super-resolution fluorescence imaging. | 
| + | - | nl | Int J Mol Sci 12(4):2518-42 (2011) |
| 238 | 2011 | Application of magnetic nanoparticles to gene delivery. | 
| + | - | nl | Int J Mol Sci 12(6):3705-22 (2011) |
| 239 | 2009 | Effect of nanoparticles on protein folding and fibrillogenesis. | 
| + | - | nl | Int J Mol Sci 10(2):646-55 (2009) |
| 240 | 2010 | Silk fibroin-derived nanoparticles for biomedical applications. | 
| + | - | nl | Nanomedicine (Lond) 5(5):807-20 (2010) |
| 241 | 2010 | Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. | 
| + | - | nl | Nanomedicine (Lond) 5(5):793-806 (2010) |
| 242 | 2010 | Nanoproteomics for nanomedicine. | 
| + | - | nl | Nanomedicine (Lond) 5(5):677-82 (2010) |
| 243 | 2011 | Targeted nanomedicine for detection and treatment of circulating tumor cells. | 
| + | - | nl | Nanomedicine (Lond) 6(4):579-81 (2011) |
| 244 | 2011 | Copolymer technology for advanced nanomedicine. | 
| + | - | nl | Nanomedicine (Lond) 6(4):583-7 (2011) |
| 245 | 2011 | Nanomedicine for oral chemotherapy. | 
| + | - | nl | Nanomedicine (Lond) 6(3):407-10 (2011) |
| 246 | 2011 | Role of nanobiotechnology in the personalized management of glioblastoma multiforme. | 
| + | - | nl | Nanomedicine (Lond) 6(3):411-4 (2011) |
| 247 | 2011 | Nanoparticle preconditioning for enhanced thermal therapies in cancer. | 
| + | - | nl | Nanomedicine (Lond) 6(3):545-63 (2011) |
| 248 | 2011 | Researching and exploiting nanomaterials useful in forensics and diagnostics. Forward. | 
| + | - | nl | Nanomedicine (Lond) 6(2):185-6 (2011) |
| 249 | 2011 | Nanofabrication techniques for controlled drug-release devices. | 
| + | - | nl | Nanomedicine (Lond) 6(1):1-6 (2011) |
| 250 | 2011 | Nanomaterials for regenerative medicine. | 
| + | - | nl | Nanomedicine (Lond) 6(1):157-81 (2011) |
| 251 | 2011 | Interview: Nanomedicine in oncology: miniaturized means to an enormous end. | 
| + | - | nl | Nanomedicine (Lond) 6(9):1495-8 (2011) |
| 252 | 2011 | The role of nanomedicine in the imaging and therapy of thrombosis. | 
| + | - | nl | Nanomedicine (Lond) 6(8):1291-3 (2011) |
| 253 | 2011 | Nanoparticles for rapid detection of microbial threats. | 
| + | - | nl | Nanomedicine (Lond) 6(8):1295-6 (2011) |
| 254 | 2011 | Nanomedicine for diabetes treatment. | 
| + | - | nl | Nanomedicine (Lond) 6(8):1297-300 (2011) |
| 255 | 2011 | Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold? | 
| + | - | nl | Nanomedicine (Lond) 6(7):1133-5 (2011) |
| 256 | 2011 | Therapeutic compliance of nanomedicine in Alzheimer's disease. | 
| + | - | nl | Nanomedicine (Lond) 6(7):1137-9 (2011) |
| 257 | 2011 | Nanotechnology for multimodal imaging. | 
| + | - | nl | Nanomedicine (Lond) 6(7):1141-4 (2011) |
| 258 | 2010 | Antibody engineering promotes nanomedicine for cancer treatment. | 
| + | - | nl | Nanomedicine (Lond) 5(8):1141-5 (2010) |
| 259 | 2010 | Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. | 
| + | - | nl | Nanomedicine (Lond) 5(3):485-505 (2010) |
| 260 | 2009 | RNAi nanoparticles in the service of personalized medicine. | 
| + | - | nl | Nanomedicine (Lond) 4(8):853-5 (2009) |
| 261 | 2010 | Microscale oral delivery devices incorporating nanoparticles. | 
| + | - | nl | Nanomedicine (Lond) 5(2):161-3 (2010) |
| 262 | 2010 | Nanogels in the race for drug delivery. | 
| + | - | nl | Nanomedicine (Lond) 5(2):165-8 (2010) |
| 263 | 2010 | Nanomedicine-based cancer targeting: a new weapon in an old war. | 
| + | - | nl | Nanomedicine (Lond) 5(1):3-5 (2010) |
| 264 | 2007 | Ethics in nanomedicine. | 
| + | - | nl | Nanomedicine (Lond) 2(3):345-50 (2007) |
| 265 | 2007 | Nanomedicine: how it could reshape clinical practice. | 
| + | - | nl | Nanomedicine (Lond) 2(4):401-5 (2007) |
| 266 | 2007 | Potential uses of carbon nanotubes in the medical field: how worried should patients be? | 
| + | - | nl | Nanomedicine (Lond) 2(4):407-10 (2007) |
| 267 | 2007 | Focus on nanoparticles for cancer diagnosis and therapeutics. | 
| + | - | nl | Nanomedicine (Lond) 2(5):647-8 (2007) |
| 268 | 2007 | Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. | 
| + | - | nl | Nanomedicine (Lond) 2(5):649-52 (2007) |
| 269 | 2007 | Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. | 
| + | - | nl | Nanomedicine (Lond) 2(6):753-8 (2007) |
| 270 | 2007 | Strategies for developing and commercializing nanobio drugs, diagnostics and devices. | 
| + | - | nl | Nanomedicine (Lond) 2(2):137-41 (2007) |
| 271 | 2007 | Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals. | 
| + | - | nl | Nanomedicine (Lond) 2(2):143-7 (2007) |
| 272 | 2009 | Nanostructured surfaces: cell engineering and cell biology. | 
| + | - | nl | Nanomedicine (Lond) 4(3):247-8 (2009) |
| 273 | 2009 | Role of nanobiotechnology in the development of personalized medicine. | 
| + | - | nl | Nanomedicine (Lond) 4(3):249-52 (2009) |
| 274 | 2009 | The photonic nanomedicine revolution: let the human side of nanotechnology emerge. | 
| + | - | nl | Nanomedicine (Lond) 4(4):369-71 (2009) |
| 275 | 2009 | Update on carbon nanotube toxicity. | 
| + | - | nl | Nanomedicine (Lond) 4(4):373-5 (2009) |
| 276 | 2009 | Conference scene - nanotoxicology: health and environmental impacts. | 
| + | - | nl | Nanomedicine (Lond) 4(4):385-90 (2009) |
| 277 | 2009 | Delivering the goods: realizing the clinical potential of RNAi. | 
| + | - | nl | Nanomedicine (Lond) 4(6):595-8 (2009) |
| 278 | 2009 | The promise of nanomedicine for ocular disease. | 
| + | - | nl | Nanomedicine (Lond) 4(6):599-604 (2009) |
| 279 | 2009 | Testing strategies for the safety of nanoparticles used in medical applications. | 
| + | - | nl | Nanomedicine (Lond) 4(6):605-7 (2009) |
| 280 | 2008 | Electron tomography in nanoparticle imaging and analysis. | 
| + | - | nl | Nanomedicine (Lond) 3(1):125-31 (2008) |
| 281 | 2008 | Role of nanomedicines in cell-based therapeutics. | 
| + | - | nl | Nanomedicine (Lond) 3(1):5-8 (2008) |
| 282 | 2008 | From fluorescence nanoscopy to nanoscopic medicine. | 
| + | - | nl | Nanomedicine (Lond) 3(1):1-4 (2008) |
| 283 | 2008 | Implications of recent US Supreme Court IP ruling for nanomedicine patents. | 
| + | - | nl | Nanomedicine (Lond) 3(2):141-3 (2008) |
| 284 | 2008 | Theranostic nanomedicine for cancer. | 
| + | - | nl | Nanomedicine (Lond) 3(2):137-40 (2008) |
| 285 | 2008 | Environmental challenges for nanomedicine. | 
| + | - | nl | Nanomedicine (Lond) 3(5):605-8 (2008) |
| 286 | 2008 | Function follows form: shape complementarity and nanoparticle toxicity. | 
| + | - | nl | Nanomedicine (Lond) 3(5):601-3 (2008) |
| 287 | 2009 | Conference scene: innovative medical devices and nanotechnology: 1-day interactive workshop. | 
| + | - | nl | Nanomedicine (Lond) 4(7):709-12 (2009) |
| 288 | 2009 | Conference scene: 2nd annual European conference for clinical nanomedicine. | 
| + | - | nl | Nanomedicine (Lond) 4(7):705-8 (2009) |
| 289 | 2009 | The future of theranostic nanoagents. | 
| + | - | nl | Nanomedicine (Lond) 4(7):693-5 (2009) |
| 290 | 2009 | Neurodegenerative disorders and nanoformulated drug development. | 
| + | - | nl | Nanomedicine (Lond) 4(5):541-55 (2009) |
| 291 | 2009 | NanoART, neuroAIDS and CNS drug delivery. | 
| + | - | nl | Nanomedicine (Lond) 4(5):557-74 (2009) Nowacek A |
| 292 | 2009 | Regulatory and scientific barriers to the safety evaluation of medical nanotechnologies. | 
| + | - | nl | Nanomedicine (Lond) 4(5):495-8 (2009) |
| 293 | 2009 | Brain targeting PBCA nanoparticles and the blood-brain barrier. | 
| + | - | nl | Nanomedicine (Lond) 4(5):499-502 (2009) |